Share:
Pune, India, March 03, 2021 (GLOBE NEWSWIRE) The global
plasma fractionation market size is expected to reach USD 48.55 billion by 2027, exhibiting a CAGR of 7.6% during the forecast period. The growing incidence of immunological disorders is expected to spur demand for the market, states Fortune Business Insights, in a report, titled Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Regional Forecast, 2020-2027. The market size stood at USD 25.44 billion in 2019.
Notable Development:
Johnson & Johnson s newly approved COVID-19 vaccine will arrive in Gaston County this week, enabling the county to reach some of its most vulnerable residents.
The 1,200 doses the agency is set to receive will double the county s weekly vaccine capacity through March 5. GEMS workers will administer those doses to protect harder-to-reach populations like homebound seniors and the homeless.
“This opportunity to get additional folks vaccinated now is possible thanks to a tremendous partnership between our department and public health,” GEMS Chief Mark Lamphiear said. “We are dedicated as an agency and a county to making sure anyone who wants a COVID-19 shot can get one.”
Chicago’s United Center will be turned into a mass COVID-19 vaccination site opening next week, but appointments will open for some residents beginning.
by Service Type (Clinical Trial Design & Consultation Services, Reading & Analytical Services, Operational Imaging Services, Project & Data Management Services, and Others), End User (Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, and Academic & Government Research Institutes), and Therapeutic Area (Oncology, Neurology, Endocrinology, Cardiology, Gastroenterology, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027. According to the report, the global clinical trial imaging services industry garnered $1.31 billion in 2019, and is expected to reach $1.80 billion by 2027, growing at a CAGR of 5.6% from 2020 to 2027.
Drivers, restraints, and opportunities
Rise in the need to outsource imaging in clinical trials, growth in adoption of imaging in clinical trials, and developments in the field of medical imaging technology drive the global clinical trial imaging services market. However, challenges associated with integration of imaging
More than 100,000 appointments for COVID-19 vaccinations at the United Center’s new mass vaccination site will open this week. Here’s a look at what you.